Author/Authors :
Cohen، نويسنده , , Mauricio G. and Tuero، نويسنده , , Enrique and Bluguermann، نويسنده , , Jorge and Kevorkian، نويسنده , , Rubén and Berrocal، نويسنده , , Daniel H. and Carlevaro، نويسنده , , Oscar and Picabea، نويسنده , , Eduardo and Hudson، نويسنده , , Michael P. and Siegel، نويسنده , , Robert J. and Douthat، نويسنده , , Lori and Greenbaum، نويسنده , , Adam B. and Echt، نويسنده , , Debra and W، نويسنده ,
Abstract :
In preclinical experiments, the combination of transcutaneous, low-frequency ultrasound and thrombolytic therapy has shown improved patency rates over thrombolytics alone. A total of 25 patients with myocardial infarction were treated with a thrombolytic agent and adjunctive transcutaneous ultrasound. No unanticipated major adverse events were observed.
